Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology

Attilio Orazi, Ronald Chiu, Dennis P. O'Malley, Magdalena Czader, Susan L. Allen, Caroline An, Gail Vance

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The World Health Organization criteria for diagnosing chronic myelomonocytic leukemia (CMML) are largely based on findings observed in the peripheral blood and bone marrow aspirate. A specific diagnostic role for the bone marrow biopsy has not been adequately explored. We examined whether bone marrow biopsy supplemented by immunohistochemistry may be helpful in distinguishing CMML from cases of chronic myelogenous leukemia and atypical chronic myeloid leukemia (aCML). We immunostained 25 cases of CMML with paraffin reactive antibodies which included CD68 (KP1), CD68R (PG-M1), and CD163, and compared the results with those observed in six cases of chronic myelogenous leukemia and in three cases of atypical CML. In addition, we examined whether CD34 immunohistochemistry could be useful in separating cases of CMML with less than 10% blasts (type-1) from cases of CMML with blasts accounting for 10-19% (type-2), and cases of CMML in acute transformation to acute myeloid leukemia (blasts≥20%). The presence of nodules of plasmacytoid monocytes was investigated by CD123 staining. CD42b was used to highlight abnormal megakaryocytes. Our results demonstrate significant differences between the groups. CD34 analysis allowed separating CMML type-1 from type-2 and the former from CMML in acute transformation. CD123-positive plasmacytoid monocyte nodules were found only in CMML and not in the other two disease groups. Overlap between CMML and the other two groups were observed with CD68 immunostaining. CD68R was more restricted to bone marrow macrophages and monocytes than CD68, but the differences between CMML and chronic myelogenous leukemia or atypical CML were still not significant. Although CD42b immunostaining facilitated the detection of dwarf megakaryocytes often present in CMML, the distinction between those and the small forms seen in chronic myelogenous leukemia was still problematic.

Original languageEnglish
Pages (from-to)1536-1545
Number of pages10
JournalModern Pathology
Volume19
Issue number12
DOIs
StatePublished - Dec 15 2006

Fingerprint

Leukemia, Myelomonocytic, Chronic
Bone Marrow
Biopsy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Monocytes
Megakaryocytes
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
Immunohistochemistry
Acute Myeloid Leukemia
Paraffin

Keywords

  • Acute transformation
  • Atypical chronic myeloid leukemia
  • Chronic myelogenous leukemia
  • Chronic myelomonocytic leukemia
  • Immunohistochemistry
  • Plasmacytoid monocyte

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Chronic myelomonocytic leukemia : The role of bone marrow biopsy immunohistology. / Orazi, Attilio; Chiu, Ronald; O'Malley, Dennis P.; Czader, Magdalena; Allen, Susan L.; An, Caroline; Vance, Gail.

In: Modern Pathology, Vol. 19, No. 12, 15.12.2006, p. 1536-1545.

Research output: Contribution to journalArticle

Orazi, Attilio ; Chiu, Ronald ; O'Malley, Dennis P. ; Czader, Magdalena ; Allen, Susan L. ; An, Caroline ; Vance, Gail. / Chronic myelomonocytic leukemia : The role of bone marrow biopsy immunohistology. In: Modern Pathology. 2006 ; Vol. 19, No. 12. pp. 1536-1545.
@article{c6d53f204a544cb4bebf75008d8d78f4,
title = "Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology",
abstract = "The World Health Organization criteria for diagnosing chronic myelomonocytic leukemia (CMML) are largely based on findings observed in the peripheral blood and bone marrow aspirate. A specific diagnostic role for the bone marrow biopsy has not been adequately explored. We examined whether bone marrow biopsy supplemented by immunohistochemistry may be helpful in distinguishing CMML from cases of chronic myelogenous leukemia and atypical chronic myeloid leukemia (aCML). We immunostained 25 cases of CMML with paraffin reactive antibodies which included CD68 (KP1), CD68R (PG-M1), and CD163, and compared the results with those observed in six cases of chronic myelogenous leukemia and in three cases of atypical CML. In addition, we examined whether CD34 immunohistochemistry could be useful in separating cases of CMML with less than 10{\%} blasts (type-1) from cases of CMML with blasts accounting for 10-19{\%} (type-2), and cases of CMML in acute transformation to acute myeloid leukemia (blasts≥20{\%}). The presence of nodules of plasmacytoid monocytes was investigated by CD123 staining. CD42b was used to highlight abnormal megakaryocytes. Our results demonstrate significant differences between the groups. CD34 analysis allowed separating CMML type-1 from type-2 and the former from CMML in acute transformation. CD123-positive plasmacytoid monocyte nodules were found only in CMML and not in the other two disease groups. Overlap between CMML and the other two groups were observed with CD68 immunostaining. CD68R was more restricted to bone marrow macrophages and monocytes than CD68, but the differences between CMML and chronic myelogenous leukemia or atypical CML were still not significant. Although CD42b immunostaining facilitated the detection of dwarf megakaryocytes often present in CMML, the distinction between those and the small forms seen in chronic myelogenous leukemia was still problematic.",
keywords = "Acute transformation, Atypical chronic myeloid leukemia, Chronic myelogenous leukemia, Chronic myelomonocytic leukemia, Immunohistochemistry, Plasmacytoid monocyte",
author = "Attilio Orazi and Ronald Chiu and O'Malley, {Dennis P.} and Magdalena Czader and Allen, {Susan L.} and Caroline An and Gail Vance",
year = "2006",
month = "12",
day = "15",
doi = "10.1038/modpathol.3800707",
language = "English",
volume = "19",
pages = "1536--1545",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Chronic myelomonocytic leukemia

T2 - The role of bone marrow biopsy immunohistology

AU - Orazi, Attilio

AU - Chiu, Ronald

AU - O'Malley, Dennis P.

AU - Czader, Magdalena

AU - Allen, Susan L.

AU - An, Caroline

AU - Vance, Gail

PY - 2006/12/15

Y1 - 2006/12/15

N2 - The World Health Organization criteria for diagnosing chronic myelomonocytic leukemia (CMML) are largely based on findings observed in the peripheral blood and bone marrow aspirate. A specific diagnostic role for the bone marrow biopsy has not been adequately explored. We examined whether bone marrow biopsy supplemented by immunohistochemistry may be helpful in distinguishing CMML from cases of chronic myelogenous leukemia and atypical chronic myeloid leukemia (aCML). We immunostained 25 cases of CMML with paraffin reactive antibodies which included CD68 (KP1), CD68R (PG-M1), and CD163, and compared the results with those observed in six cases of chronic myelogenous leukemia and in three cases of atypical CML. In addition, we examined whether CD34 immunohistochemistry could be useful in separating cases of CMML with less than 10% blasts (type-1) from cases of CMML with blasts accounting for 10-19% (type-2), and cases of CMML in acute transformation to acute myeloid leukemia (blasts≥20%). The presence of nodules of plasmacytoid monocytes was investigated by CD123 staining. CD42b was used to highlight abnormal megakaryocytes. Our results demonstrate significant differences between the groups. CD34 analysis allowed separating CMML type-1 from type-2 and the former from CMML in acute transformation. CD123-positive plasmacytoid monocyte nodules were found only in CMML and not in the other two disease groups. Overlap between CMML and the other two groups were observed with CD68 immunostaining. CD68R was more restricted to bone marrow macrophages and monocytes than CD68, but the differences between CMML and chronic myelogenous leukemia or atypical CML were still not significant. Although CD42b immunostaining facilitated the detection of dwarf megakaryocytes often present in CMML, the distinction between those and the small forms seen in chronic myelogenous leukemia was still problematic.

AB - The World Health Organization criteria for diagnosing chronic myelomonocytic leukemia (CMML) are largely based on findings observed in the peripheral blood and bone marrow aspirate. A specific diagnostic role for the bone marrow biopsy has not been adequately explored. We examined whether bone marrow biopsy supplemented by immunohistochemistry may be helpful in distinguishing CMML from cases of chronic myelogenous leukemia and atypical chronic myeloid leukemia (aCML). We immunostained 25 cases of CMML with paraffin reactive antibodies which included CD68 (KP1), CD68R (PG-M1), and CD163, and compared the results with those observed in six cases of chronic myelogenous leukemia and in three cases of atypical CML. In addition, we examined whether CD34 immunohistochemistry could be useful in separating cases of CMML with less than 10% blasts (type-1) from cases of CMML with blasts accounting for 10-19% (type-2), and cases of CMML in acute transformation to acute myeloid leukemia (blasts≥20%). The presence of nodules of plasmacytoid monocytes was investigated by CD123 staining. CD42b was used to highlight abnormal megakaryocytes. Our results demonstrate significant differences between the groups. CD34 analysis allowed separating CMML type-1 from type-2 and the former from CMML in acute transformation. CD123-positive plasmacytoid monocyte nodules were found only in CMML and not in the other two disease groups. Overlap between CMML and the other two groups were observed with CD68 immunostaining. CD68R was more restricted to bone marrow macrophages and monocytes than CD68, but the differences between CMML and chronic myelogenous leukemia or atypical CML were still not significant. Although CD42b immunostaining facilitated the detection of dwarf megakaryocytes often present in CMML, the distinction between those and the small forms seen in chronic myelogenous leukemia was still problematic.

KW - Acute transformation

KW - Atypical chronic myeloid leukemia

KW - Chronic myelogenous leukemia

KW - Chronic myelomonocytic leukemia

KW - Immunohistochemistry

KW - Plasmacytoid monocyte

UR - http://www.scopus.com/inward/record.url?scp=33751206504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751206504&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800707

DO - 10.1038/modpathol.3800707

M3 - Article

C2 - 17041567

AN - SCOPUS:33751206504

VL - 19

SP - 1536

EP - 1545

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 12

ER -